347 related articles for article (PubMed ID: 7667382)
1. Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity.
Yoburn BC; Shah S; Chan K; Duttaroy A; Davis T
Pharmacol Biochem Behav; 1995; 51(2-3):535-9. PubMed ID: 7667382
[TBL] [Abstract][Full Text] [Related]
2. Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption.
White DA; Ballard ME; Harmon AC; Holtzman SG
Brain Res Bull; 2008 Aug; 76(6):597-604. PubMed ID: 18598850
[TBL] [Abstract][Full Text] [Related]
3. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
4. Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociception.
Kest B; Lee CE; Jenab S; Kao B; Inturrisi CE
Eur J Pharmacol; 1998 Mar; 345(1):47-53. PubMed ID: 9593593
[TBL] [Abstract][Full Text] [Related]
5. Magnitude of tolerance to fentanyl is independent of mu-opioid receptor density.
Chan KW; Duttory A; Yoburn BC
Eur J Pharmacol; 1997 Jan; 319(2-3):225-8. PubMed ID: 9042594
[TBL] [Abstract][Full Text] [Related]
6. Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice.
Duttaroy A; Shen J; Shah S; Chen B; Sehba F; Carroll J; Yoburn BC
Life Sci; 1999; 65(2):113-23. PubMed ID: 10416817
[TBL] [Abstract][Full Text] [Related]
7. Chronic d-amphetamine inhibits opioid receptor antagonist-induced supersensitivity.
Duttaroy A; Billings B; Candido J; Yoburn BC
Eur J Pharmacol; 1992 Oct; 221(2-3):211-5. PubMed ID: 1330622
[TBL] [Abstract][Full Text] [Related]
8. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
9. The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity.
Lee SC; Yoburn BC
Pharmacol Biochem Behav; 2000 Jun; 66(2):347-51. PubMed ID: 10880689
[TBL] [Abstract][Full Text] [Related]
10. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes.
Spanagel R; Almeida OF; Shippenberg TS
Eur J Pharmacol; 1994 Oct; 264(2):157-62. PubMed ID: 7851478
[TBL] [Abstract][Full Text] [Related]
11. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ.
Mogil JS; Grisel JE; Zhangs G; Belknap JK; Grandy DK
Neurosci Lett; 1996 Aug; 214(2-3):131-4. PubMed ID: 8878101
[TBL] [Abstract][Full Text] [Related]
12. A lack of supersensitivity to opioid receptor agonists following chronic spinal opioid receptor antagonist administration in the rat.
Keck BJ; Stafinsky JL; Uram M; Crisp T
Gen Pharmacol; 1995 Jan; 26(1):161-8. PubMed ID: 7713356
[TBL] [Abstract][Full Text] [Related]
13. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
Tao R; Auerbach SB
J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
[TBL] [Abstract][Full Text] [Related]
14. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
15. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
16. Opioidergic modulation of ethanol self-administration in the ventral pallidum.
Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K
Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
Suh HH; Tseng LF
Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
[TBL] [Abstract][Full Text] [Related]
18. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
Hammond DL; Stewart PE; Littell L
J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
[TBL] [Abstract][Full Text] [Related]
19. Opioid antagonist-induced receptor upregulation: effects of concurrent agonist administration.
Yoburn BC; Duttaroy A; Shah S; Davis T
Brain Res Bull; 1994; 33(2):237-40. PubMed ID: 8275346
[TBL] [Abstract][Full Text] [Related]
20. Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation.
Nelson CJ; Schneider GM; Lysle DT
Brain Behav Immun; 2000 Sep; 14(3):170-84. PubMed ID: 10970678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
